BioLineRx Ltd. (BLRX) Fundamentals

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the treatment of skin lesions.
SHARE INFORMATION
Market CapUS$ 44.020.773
Shares Outstanding61.524.491
Float61.524.491
Percent Float100,0%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0,60
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions38
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months33.829
Institutional Holdings Percent6,5%
Institutional Sold Previous 3 Months160.602
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0,0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week HighUS$ 3,02
52 Week LowUS$ 0,57
52 Week High ChangeUS$ -69,16
21 Day Moving AverageUS$ 0,716
21 Day Extended Moving AverageUS$ 0,727374
50 Day Moving AverageUS$ 0,8066
50 Day Extended Moving AverageUS$ 0,85633
200 Day Moving AverageUS$ 1,2988
200 Day Extended Moving AverageUS$ 1,3345
10 Day Average Volume229.175
20 Day Average Volume537.744
30 Day Average Volume430.334
50 Day Average Volume337.308
Alpha-0.049757
Beta1.7902
Standard Deviation0.181308
R20.276072
7 Day Price ChangeUS$ 0,0233
7 Day Percent Change3,37%
21 Day Price ChangeUS$ 0,0755
21 Day Percent Change11,8%
30 Day Price ChangeUS$ -0,1445
30 Day Percent Change-16,8%
Month to Date Price ChangeUS$ 0,0106
Month to Date Percent Change1,5%
Quarter to Date Price ChangeUS$ -0,2095
Quarter to Date Percent Change-22,65%
180 Day Price ChangeUS$ -0,7445
180 Day Percent Change-50,99%
200 Day Price ChangeUS$ -0,4445
200 Day Percent Change-38,32%
Year to Date Price ChangeUS$ -1,32
Year to Date Percent Change-64,93%

BioLineRx Ltd. (BLRX) Key Ratios

PROFITABILITY
EBIT Margin0,0%
EBITDA Margin0,0%
Pre-Tax Profit Margin0,0%
Profit Margin Count0,0%
Gross Margin0,0%
Profit Margin TOT0,0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0,00
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book0,80
Total Debt To Equity0,20
Int Coverage-22,20
Current Ratio7,10
Leverage Ratio1,30
Quick Ratio7,10
Long Term Debt To Capital0,15
VALUATION MEASURES
PE Ratio-1,50
Enterprise ValueUS$ 330.791
Price to Sales0,00
Price to Free Cash-1,60
PE High Last 5 Years-1,40
Price To Book0,80
Price To Cash Flow0,00
PE Low Last 5 Years-2,90
Price to Tangible Book0,80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0,00
Invoice Turnover0,00
Assets Turnover0,00
Return Assets-27,91
Return on Equity-37,21
Return on Capital-32,28

BioLineRx Ltd. (BLRX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeDR
AuditorKesselman & Kesselman C.P.A.s
CEOPhilip Serlin
Emplyoees38
Last AuditUQ
CIK0001498403
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
Address2 HaMa'ayan Street
Modi'in, 7177871
Websitehttp://www.biolinerx.com
Facsimile+972 86429101
Telephone+972 86429100
EmailIR@biolinerx.com
Seu Histórico Recente
NASDAQ
BLRX
BioLineRx
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20221205 07:31:18